Page last updated: 2024-09-04

pomalidomide and acy-1215

pomalidomide has been researched along with acy-1215 in 1 studies

Compound Research Comparison

Studies
(pomalidomide)
Trials
(pomalidomide)
Recent Studies (post-2010)
(pomalidomide)
Studies
(acy-1215)
Trials
(acy-1215)
Recent Studies (post-2010) (acy-1215)
6231215521171114

Protein Interaction Comparison

ProteinTaxonomypomalidomide (IC50)acy-1215 (IC50)
Histone deacetylase 6Danio rerio (zebrafish)0.09
Histone deacetylase 3Homo sapiens (human)0.063
Histone deacetylase 4Homo sapiens (human)7
Histone deacetylase 1Homo sapiens (human)0.0861
Histone deacetylase 7Homo sapiens (human)1.4
Histone deacetylase 2Homo sapiens (human)0.1116
Polyamine deacetylase HDAC10Homo sapiens (human)0.6349
Histone deacetylase 8Homo sapiens (human)0.1712
Histone deacetylase 6Homo sapiens (human)0.084
Histone deacetylase 5Homo sapiens (human)5
Nuclear receptor corepressor 2Homo sapiens (human)0.0463

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Chen, W; Li, J; Liu, X; Shi, J; Zhang, Z; Zhao, L; Zhou, Y1

Reviews

1 review(s) available for pomalidomide and acy-1215

ArticleYear
A review on the treatment of multiple myeloma with small molecular agents in the past five years.
    European journal of medicinal chemistry, 2022, Feb-05, Volume: 229

    Topics: Animals; Antineoplastic Agents; Biomarkers, Tumor; Combined Modality Therapy; Deubiquitinating Enzymes; Drug Development; Drug Resistance; Histone Deacetylases; Humans; Ikaros Transcription Factor; Immunomodulating Agents; Models, Molecular; Morpholines; Multiple Myeloma; Phthalimides; Piperidones; Proteasome Inhibitors; Treatment Outcome; Ubiquitin-Protein Ligases

2022